VA Trials GLP-1 Medication for Veterans with Alcohol Use Disorder
The Department of Veterans Affairs is launching a nationwide clinical trial to determine whether semaglutide can help treat alcohol use disorder, a condition officially diagnosed in more than 400,000 veterans nationwide, according to department data. VA researchers are studying the GLP-1 receptor agonist—marketed as Ozempic for Type 2 diabetes and Wegovy for chronic weight management—to … Read more